Literature DB >> 32178386

Serum Uric Acid is Associated with Renal Prognosis of Lupus Nephritis in Women but not in Men.

Tae Ryom Oh1, Hong Sang Choi1, Chang Seong Kim1, Dong-Ryeol Ryu2, Sun-Hee Park3, Shin Young Ahn4, Soo Wan Kim1, Eun Hui Bae1, Seong Kwon Ma1.   

Abstract

Lupus nephritis (LN) is a major complication of systemic lupus erythematosus. Early intervention in lupus nephritis improves prognosis. There is an association between hyperuricemia and lupus nephritis; nevertheless, the sex-specific role of uric acid in lupus nephritis remains unclear. We retrospectively analyzed 578 patients diagnosed with LN by renal biopsy. We determine the relationship of serum uric acid to progression of LN using Kaplan-Meier survival analyses and Cox proportional hazards models. The primary end point was LN progression defined as the initiation of dialysis or kidney transplantation. Men had higher mean serum uric acid levels than did women. Every 1 mg/dL increase in baseline uric acid level increased the risk of LN progression by 15.1%. The serum uric acid level was an independent risk factor for LN progression in women (hazard ratio [HR], 1.158; confidence interval [CI], 1.018-1.317; p = 0.028) but not in men (HR, 1.499; CI, 0.964-2.331; p = 0.072). Sensitivity analysis involving serum uric acid terciles generated consistent and robust results. Serum uric acid level was an independent risk factor for LN progression in women but not in men.

Entities:  

Keywords:  end stage renal disease; hyperuricemia; lupus nephritis; prognosis; proportional hazard models; sex; systemic lupus erythematosus; uric acid

Year:  2020        PMID: 32178386     DOI: 10.3390/jcm9030773

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

1.  Clinicopathological Patterns and Outcomes in Patients with Lupus Nephritis and Hyperuricemia.

Authors:  Qiong Wen; Xueqing Tang; Qian Zhou; Wei Chen; Xueqing Yu
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.